Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: A cross-sectional population study

American Journal of Clinical Nutrition

Volumn 88, Issue 2, 2008, Pages 392-397

  Norat, Teresa ^a   Bowman, Richard ^a,b   Luben, Robert ^b   Welch, Ailsa ^b   Kay, Tee Khaw ^b   Wareham, Nick ^b   Bingham, Sheila ^a,b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BIOLOGICAL MARKER; POTASSIUM; SODIUM;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIGENOMICS; POPULATION RESEARCH; POTASSIUM URINE LEVEL; SALT INTAKE; SODIUM INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 49449109048     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/88.2.392     Document Type: Article

References (39)

1. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988;297:319-28.
2. Chobanian AV, Hill M. National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure: a critical review of current scientific evidence. Hypertension 2000;35:858-63.
3. Frost CD, Law MR, Wald NJ. By how much does dietary salt reduction lower blood pressure? II - Analysis of observational data within populations. BMJ 1991;302:815- 8.
4. Khaw KT, Bingham S, Welch A, et al. Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Am J Clin Nutr 2004;80:1397-403.
5. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996;275:1590-7.
6. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10.
7. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997;29:1078-82.
8. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
9. Rotimi C, Cooper R, Ogunbiyi O, et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997;95:2348-50.
10. Schorr U, Blaschke K, Beige J, Distler A, Sharma AM. Angiotensinogen M235T variant and salt sensitivity in young normotensive Caucasians. J Hypertens 1999;17:475-9.
11. Morgan T, Craven C, Nelson L, Lalouel JM, Ward K. Angiotensinogen T235 expression is elevated in decidual spiral arteries. J Clin Invest 1997;100:1406-15.
12. Svetkey LP, Moore TJ, Simons-Morton DG, et al. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 2001;19:1949-56.
13. Hunt SC, Cook NR, Oberman A, et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension 1998;32:393-401.
14. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-97.
15. Brand E, Chatelain N, Paillard F, et al. Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis. Eur J Hum Genet 2002;10:715-23.
16. Brand-Herrmann SM, Kopke K, Reichenberger F, et al. Angiotensinogen promoter haplotypes are associated with blood pressure in untreated hypertensives. J Hypertens 2004;22:1289-97.
17. Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997;60:1448-60.
18. Sun B, Dronma T, Qin WJ, et al. Polymorphisms of renin-angiotensin system in essential hypertension in Chinese Tibetans. Biomed Environ Sci 2004;17:209-16.
19. Tian HG, Guo ZY, Hu G, et al. Changes in sodium intake and blood pressure in a community-based intervention project in China. J Hum Hypertens 1995;9:959-68.
20. The INTERSALT study. An international co-operative study of electrolyte excretion and blood pressure: further results. J Hum Hypertens 1989;3:279-407.
21. Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 1996;312:1249-53.
22. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I - Analysis of observational data among populations. BMJ 1991;302:811-5.
23. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999;80(suppl):95-103.
24. Bingham SA, Gill C, Welch A, et al. Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 1997;26(suppl):S137-51.
25. McKeown NM, Day NE, Welch AA, et al. Use of biological markers to validate self-reported dietary intake in a random sample of the European Prospective Investigation into Cancer United Kingdom Norfolk cohort. Am J Clin Nutr 2001;74:188-96.
26. Welch AA, McTaggart A, Mulligan AA, et al. DINER (Data Into Nutrients for Epidemiological Research) - a new data-entry program for nutritional analysis in the EPIC-Norfolk cohort and the 7-day diary method. Public Health Nutr 2001;4:1253-65.
27. Ahmadian A, Gharizadeh B, Gustafsson AC, et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 2000;280:103-10.
28. Alderborn A, Kristofferson A, Hammerling U. Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res 2000;10:1249-58.
29. Nyren P, Karamohamed S, Ronaghi M. Detection of single-base changes using a bioluminometric primer extension assay. Anal Biochem 1997;244:367-73.
30. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P. Realtime DNA sequencing using detection of pyrophosphate release. Anal Biochem 1996;242:84-9.
31. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-10.
32. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. In: Egger M, Smith GD, Altman D, eds. Systematic reviews in health care. Meta-analysis in context. 2nd ed. London, United Kingdom: BMJ Books, 2001:285-312.
33. Watt GC, Foy CJ. Dietary sodium and arterial pressure: problems of studies within a single population. J Epidemiol Community Health 1982;36:197-201.
34. Low YL, Dunning AM, Dowsett M, et al. Implications of gene-environment interaction in studies of gene variants in breast cancer: an example of dietary isoflavones and the D356N polymorphism in the sex hormone-binding globulin gene. Cancer Res 2006;66:8980-3.
35. Joossens JV, Kesteloot H. Trends in systolic blood pressure, 24-hour sodium excretion, and stroke mortality in the elderly in Belgium. Am J Med 1991;90:5S-11S.
36. Sciarrone SE, Beilin LJ, Rouse IL, Rogers PB. A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects. J Hypertens 1992;10:287-98.
37. Johnson AG, Nguyen TV, Davis D. Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects. J Hypertens 2001;19:1053-60.
38. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004;CD004937.
39. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de La Sierra A. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001;38:1204-9.